Carasent AB (publ) (STO:CARA)
Sweden · Delayed Price · Currency is SEK 24.45
+0.70 (2.95%)
May 6, 2026, 5:29 PM CET
Carasent AB Market Cap
Carasent AB has a market cap or net worth of 1.63 billion as of May 6, 2026. Its market cap has decreased by -1.95% in one year.
Market Cap
1.63B
Enterprise Value
1.53B
Revenue
349.05M
Ranking
n/a
PE Ratio
40.38
Stock Price
24.45
Market Cap Chart
Since December 12, 2012, Carasent AB's market cap has increased from 48.86M to 1.63B, an increase of 3,228.27%. That is a compound annual growth rate of 29.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.63B | -15.30% |
| Dec 30, 2025 | 1.92B | 19.57% |
| Dec 30, 2024 | 1.61B | 3,186.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 147.95B |
| Getinge AB | 49.99B |
| Sectra AB | 49.17B |
| Camurus AB | 31.73B |
| Saniona AB | 1.93B |
| Cereno Scientific AB | 1.90B |
| Surgical Science Sweden AB | 1.67B |
| Devyser Diagnostics AB | 1.58B |